Press & News
See our latest news and press coverage
Press Release
April 25, 2025
Precision for Medicine and PathAI Announce Strategic Collaboration to Advance AI-Powered Clinical Trial Services and Biospecimen Products
Read MorePress Release
April 21, 2025
PathAI Announces Poster Presentations at the 2025 American Association of Cancer Research Annual Meeting
Read MorePress Release
March 25, 2025
PathAI Showcases AI-Powered Pathology Innovations at the United States and Canadian Academy of Pathology (USCAP) 114th Annual Meeting
Read MorePress Release
March 24, 2025
PathAI Expands AISight® Digital Pathology Adoption with Four New Laboratory Partners
Read MorePress Release
March 20, 2025
PathAI Announces EMA Qualification for AIM-MASH AI Assist, a Groundbreaking AI Tool for MASH Clinical Trials
Read MorePress Release
February 11, 2025
PathAI and Rede D’Or Announce Strategic Partnership to Bring AI-Powered Pathology Solutions to Brazil
Read MorePress Release
February 4, 2025
PathAssist Derm Launches on AISight®: Advancing Dermatopathology Research Workflows using AI
Read MorePress Release
January 23, 2025
PathAI Partners with Discovery Life Sciences to Deploy First AI-Powered Biospecimen Solutions
Read MorePress Release
December 9, 2024
PathAI Launches AIM-IHC Breast Panel on AISight® Platform to Streamline Breast Cancer Biomarker Quantification and Improve Pathologist Efficiency
Read MorePress Release
November 25, 2024
PathAI Recognized for the “Diagnostics Innovation of the Year” By BioTech Breakthrough
Read MorePress Release
November 21, 2024
PathAI Ranked 420th Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
Read MorePress Release
November 19, 2024
PathAI Announces Integrations with Leading AI-pathology companies Deep Bio, DoMore Diagnostics, Paige, and Visiopharm, through its AISight Image Management System
Read MorePress Release
November 4, 2024
PathAI Launches PathExplore Fibrosis: An AI-Powered Pathology Breakthrough in Fibrosis, Collagen, and Fiber Quantification Directly from Whole Slide Images
Read MorePress Release
e
October 31, 2024
RVIZIA Diagnostics Selects PathAI and the AISight Image Management System to Support the Transition to Digital and AI-Powered Pathology
Read MorePress Release
October 23, 2024
PathAI Unveils New Features on AISight® Image Management System: Introducing Guided Algorithm Review and Z-Stack Image Support
Read MorePress Release
October 11, 2024
PathAI Chief Medical Officer Eric Walk Named to PharmaVoice 100 List
Read MorePress Release
October 10, 2024
Clario and PathAI Collaborate to Deliver Integrated Solution for GI Clinical Trials
Read MorePress Release
October 3, 2024
PathAI Announces Collaboration with the Crohn’s & Colitis Foundation to Advance Novel IBD Research and Development
Read MorePress Release
September 10, 2024
PathAI Launches MET Predict on AISight to Enhance NSCLC Assessments
Read MorePress Release
September 3, 2024
PathAI Collaborates with GoldPath to Elevate Digital Pathology Capabilities with AISight Image Management System
Read MorePress Release
August 28, 2024
PathAI's AISightⓇ Dx Image Management System is CE Marked for Primary Diagnosis
Read MorePress Release
August 13, 2024
PathAI Announces Launch of AI-based Measurement of Metabolic Dysfunction-Associated Steatohepatitis ("AIM-MASH") on the AISight Image Management System
Read MorePress Release
June 11, 2024
Quest Diagnostics Completes Acquisition of Select PathAI Diagnostics’ Lab Assets from PathAI, Accelerating Adoption of AI and Digital Pathology to Speed Cancer Diagnosis
Read MorePress Release
June 3, 2024
PathAI to present AI-powered research insights at the European Association for the Study of the Liver Congress 2024
Read MorePress Release
May 29, 2024
PathAI Expands Portfolio of AI-Powered Products, Announcing PathExplore™ IOP and IHC Explore™ Ahead of ASCO 2024
Read MorePress Release
May 23, 2024
PathAI and Aster Insights Partner to Deliver Combined AI-Derived Structured Pathology and Multimodal Real-World Data Solutions
Read MorePress Release
May 21, 2024
PathAI Announces Early Access Program to Drive Adoption of AISight Image Management System in Anatomic Pathology Laboratories Across Mainland Europe
Read MorePress Release
May 16, 2024
PathAI Welcomes Mary Padilla, M.D., To Lead Clinical Development Services for Biopharma
Read MorePress Release
May 14, 2024
PathAI announces PLUTO: a state-of-the-art Foundation Model to enhance AI-powered pathology tools
Read MorePress Release
May 9, 2024
The Boston Globe Names Andy Beck to Tech Power Players 50
Read MorePress Release
May 1, 2024
Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAI
Read MorePress Release
April 25, 2024
Hoag Health System Selects PathAI and the AISight Image Management System to Support the Transition To Digital and AI-enabled Pathology
Read MorePress Release
April 16, 2024
PathAI Partners with Google Cloud to Transform Drug Discovery and Precision Medicine Through AI-Powered Pathology
Read MorePress Release
April 3, 2024
PathAI Announces Research Presentations at the 2024 AACR Annual Meeting
Read MorePress Release
March 21, 2024
Quantum Pathology Enhances Digital Pathology Capabilities with the Adoption of PathAI's AISight Image Management System
Read MorePress Release
February 27, 2024
PathAI Launches New Pathologist-Centric Features on AISight to Enable Efficient Case Review through Intelligent Case Prioritization and Real-Time Multi-Institutional Collaboration
Read MorePress Release
February 13, 2024
PathAI Announces Exclusive Collaboration with Roche Tissue Diagnostics to Advance AI-enabled Interpretation for Companion Diagnostics
Read MorePress Release
January 30, 2024
PathAI launches six additional oncology indications for PathExplore, an AI-powered pathology panel for spatial analysis of the tumor microenvironment
Read MorePress Release
January 16, 2023
PathAI Commences New Year with Strong Foundation for Growth Following Key 2023 Achievements in AI-Powered Pathology Products, Strategic Partnerships, and Leadership Team Hires
Read MorePress Release
December 14, 2023
PathAI Introduces TumorDetect, an AI Solution to Automate Tumor Assessment and Case Prioritization for Anatomic Pathology Labs
Read MorePress Release
December 5, 2023
PathAI Announces Research Presentations at the San Antonio Breast Cancer Symposium
Read MorePress Release
November 30, 2023
PathAI Launches ArtifactDetect Model on AISight, Pioneering Automated Slide Quality Analysis in Pathology Labs
Read MorePress Release
November 16, 2023
PathAI Announces AISight Support of DICOM Standards and Commits to Being a Leader in Integrated Enterprise Image Architecture and Strategy
Read MorePress Release
November 10, 2023
PathAI Announces Research Presentations at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting
Read MorePress Release
November 2, 2023
PathAI Announces New NASH/MASH Advisory Network to Guide Evidence Generation and Regulatory Strategy for Product Development
Read MorePress Release
October 31, 2023
PathAI Announces Research Presentations at the Society for Immunotherapy of Cancer's 38th Annual Meeting
Read MorePress Release
October 19, 2023
PathAI Diagnostics Unveils World's First AI-Assisted Laboratory Developed Test for MASLD and MASH
Read MorePress Release
October 18, 2023
PathAI Announces Launch of AIM-TumorCellularity (AIM-TC), an AI-Based Tumor Cellularity Assessment Product, to Inform Advanced Molecular Testing
Read MorePress Release
October 11, 2023
PathAI Announces Research Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Read MorePress Release
September 19, 2023
PathAI Announces Expansion of BioPharma Lab to Provide End-to-End Central Pathology and Histology Services
Read MorePress Release
September 6, 2023
PathAI Launches AISight Link to Support Integration Solutions for Laboratory Customers and Biopharma Partners
Read MorePress Release
August 29, 2023
FNIH and PathAI Forge Partnership to Advance Mucosal Healing in Ulcerative Colitis Research
Read MorePress Release
August 17, 2023
PathAI Announces Commercial Availability of AISight Digital Pathology Image Management System to Power the Next Generation of Pathology Labs
Read MorePress Release
July 27, 2023
PathAI Launches its AI-Powered PathExplore Data Access Program For Academic Researchers
Read MorePress Release
July 20, 2023
PathAI Launches AIM-HER2 Breast Cancer, an Artificial Intelligence-Powered HER2 Scoring Algorithm for Biopharma Research and Clinical Labs
Read MorePress Release
June 21, 2023
PathAI will Present on Analytical and Clinical Validation of AI-based NASH Clinical Trial Digital Pathology Tool at the European Association for the Study of the Liver Congress 2023, and Announces Launch of new NASH Explore Product
Read MorePress Release
June 14, 2023
PathAI Announces New Executive Appointment to Drive Commercial Growth of Biopharma Partnerships, Lab Capabilities, and Clinical Innovation
Read MorePress Release
May 17, 2023
PathAI Announces IBD Explore, an AI-powered Histopathology Panel to Unlock Insights for Ulcerative Colitis from the Inflammatory Microenvironment
Read MorePress Release
April 25, 2023
PathAI and ConcertAI Partner to Create First-in-class Histopathology and Curated Clinical Real-World Data Product
Read MorePress Release
April 12, 2023
Agilent and PathAI Partner to Deliver AI-Powered Assay Development Solutions for Biopharma Research and Clinical Applications
Read MorePress Release
April 11, 2023
PathAI to Present on AI-based Models to Advance Tumor Analysis and Oncology Drug Development at American Association for Cancer Research Annual Meeting 2023
Read MorePress Release
April 4, 2023
PathAI Announces PathExplore, an AI-powered Pathology Panel to Unlock Untapped Insights from the Tumor Microenvironment
Read MorePress Release
March 30, 2023
PathAI Announces Collaboration with GSK on NASH Phase 2b Clinical Trial
Read MorePress Release
March 9, 2023
PathAI Announces Early Adoption of its Digital Pathology Platform and Algorithms by Leading Anatomic Pathology Laboratories
Read MorePress Release
February 16, 2023
PathAI Announces Two New Executives to Expand Regulatory Expertise and Precision Oncology Commercial Strategy
Read MorePress Release
November 7, 2022
PathAI to Present on AI Models Supporting Advances in Oncology Research at Society for Immunotherapy of Cancer Annual Meeting
Read MorePress Release
November 2, 2022
PathAI to Present Recent Advances in Applying AI-Powered Pathology Towards Liver Disease at the American Association for the Study of Liver Diseases (AASLD) 2022 Liver Meeting
Read MorePress Release
August 25, 2022
PathAI Announces Extension of Multi-Year Collaboration Agreement with Bristol Myers Squibb
Read MorePress Release
August 12, 2022
PathAI Receives Both FDA 510(k) Clearance and CE Mark for AISight Dx Platform
Read MorePress Release
August 4, 2022
PathAI Research Shows Power of Artificial Intelligence to Predict Biomarkers from H&E Images
Read MorePress Release
July 14, 2022
PathAI Appoints Brandon Eldredge as Chief Financial Officer
Read MorePress Release
June 30, 2022
PathAI Appoints Elizabeth Storti as Chief People Officer
Read MorePress Release
June 8, 2022
PathAI To Present Three Abstracts at International Liver Congress 2022
Read MorePress Release
April 8, 2022
PathAI Announces Upcoming Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Read MorePress Release
April 5, 2022
PathAI and GlaxoSmithKline Sign Multi-Year Agreement to Accelerate Research and Drug Development
Read MorePress Release
March 10, 2022
PathAI and Cleveland Clinic Announce Collaboration to Build Digital Pathology Infrastructure and Evolve Use of AI-Powered Pathology Algorithms in Research and Clinical Care
Read MorePress Release
December 21, 2021
PathAI Announces Collaboration with Akoya Biosciences to Offer a Spatial Biology and AI-Powered Analysis Solution
Read More